SCN2A ENCEPHALOPATHY

Clinical trials for SCN2A ENCEPHALOPATHY explained in plain language.

Never miss a new study

Get alerted when new SCN2A ENCEPHALOPATHY trials appear

Sign up with your email to follow new studies for SCN2A ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for babies with rare seizure disorder: drug trial targets SCN2A gene

Disease control Recruiting now

This study tests a medicine called elsunersen in 40 children with a rare, severe form of epilepsy caused by changes in the SCN2A gene. The goal is to see if the drug can safely reduce how often seizures happen over 24 weeks. Children must have started having seizures before 3 mon…

Matched conditions: SCN2A ENCEPHALOPATHY

Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC

SCN2A ENCEPHALOPATHY

Get alerted when new SCN2A ENCEPHALOPATHY trials appear

New hope for babies with rare seizure disorder: drug trial targets SCN2A gene